Kateterburen slutning av persisterande foramen ovale. (PFO)

More documents

Recommendations

Info

Exkluderade studier: Delaney JW, Li JS, Rhodes JF. Major complications associated with transcatheter atrial septal occluder implantation: a review of the medical literature and the manufacturer and user facility device experience (MAUDE) database. Congenit Heart Dis. 2007 Jul;2(4):256-64. Haute Autorite de Sante/French National Authority for H. Transcatheter closure of a patent foramen ovale. Paris: Haute Autorite de Sante (French National Authority for Health) (HAS); 2006. Spies C, Khandelwal A, Timmemanns I, Kavinsky CJ, Schräder R, Hijazi ZM. Recurrent events following patent foramen ovale closure in patients above 55 years of age with presumed paradoxical embolism. Catheter Cardiovasc Interv. 2008 Dec 1;72(7):966-70. Spies C, Khandelwal A, Timmermanns I, Schräder R. Incidence of atrial fibrillation following transcatheter closure of atrial septal defects in adults. Am J Cardiol. 2008 Oct 1;102(7):902-6. Wahl A, Kunz M, Moschovitis A, Nageh T, Schwerzmann M, Seiler C et al. Long-term results after fluoroscopy-guided closure of patent foramen ovale for secondary prevention of paradoxical embolism. Heart. 2008 Mar;94(3):336-41. Wahl A, Praz F, Stinimann J, Windecker S, Seiler C, Nedeltchev K et al. Safety and feasibility of percutaneous closure of patent foramen ovale without intra-procedural echocardiography in 825 patients. Swiss Med Wkly. 2008 Oct 4;138(39-40):567-72. Övrigt: Di Tullio MR, Sacco RL, Sciacca RR, Jin Z, Homma S. Patent foramen ovale and the risk of ischemic stroke in a multiethnic population. J Am Coll Cardiol. 2007 Feb 20;49(7):797-802. Drighil A, El Mosalami H, Elbadaoui N, Chraibi S, Bennis A. Patent foramen ovale: a new disease? Int J Cardiol. 2007 Oct 31;122(1):1-9. GRADE Working Group. Grading quality of evidence and strength of recommendations. BMJ. 2004 Jun 19;328(7454):1490-4. GRADE Working Group. List of GRADE working group publications and grants [Internet]. [Place unknown]: GRADE Working Group, c2005-2009 [cited 2010 Mar 9]. Available from: http://www.gradeworkinggroup.org/publications/index.htm Handke M, Harloff A, Olschewski M, Hetzel A, Geibel A. Patent foramen ovale and cryptogenic stroke in older patients. N Engl J Med. 2007 Nov 29;357(22):2262-8. Homma S, Sacco RL. Patent foramen ovale and stroke. Circulation. 2005 Aug 16;112(7):1063-72. Jood K, Ladenvall C, Rosengren A, Blomstrand C, Jern C. Family history in ischemic stroke before 70 years of age: the Sahlgrenska Academy Study on Ischemic Stroke. Stroke. 2005 Jul;36(7):1383-7. Meissner I, Khandheria BK, Heit JA, Petty GW, Sheps SG, Schwartz GL et al. Patent foramen ovale: innocent or guilty? Evidence from a prospective population-based study. J Am Coll Cardiol. 2006 Jan 17;47(2):440-5. Moher D, Liberati A, Tetzlaff J, Altman DG; PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009 Jul 21;6(7):e1000097.
Sahlgrenska Universitetssjukhuset, HTA-centrum Röda Stråket 8, 413 45 Göteborg www.sahlgrenska.se/hta-centrum
Page 1 and 2: Health Technology Assessment HTA-ra
Page 3 and 4: Kvalitetssäkringsprocess Extern gr
Page 5 and 6: Evidensläge för studerad patientn
Page 7 and 8: Risks The risk of atrial fibrillati
Page 9 and 10: Vilken metod vill ni utvärdera? Sl
Page 11 and 12: 2c. Nuvarande handläggning av den
Page 13 and 14: 3d. Ange PICO P= Patients, I= Inter
Page 15 and 16: Primärt utfall: Ny stroke/TIA I j
Page 17 and 18: Etiska aspekter 7a. Etiska konsekve
Page 19 and 20: Ekonomi 9a. Nuvarande kostnader? N
Page 21 and 22: Obesvarade frågeställningar 10a.
Page 23 and 24: Bilaga 1 Resultattabell per utfalls
Page 31 and 32: Bilaga 3: Litteratursökningsproces
Page 33 and 34: The Cochrane Library 2010-05-03 For
Page 35: Litteraturlista Inkluderade studier

Kateterburen slutning av persisterande foramen ovale. (PFO)

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?